Sponsor
Boyer B et al. – In this preliminary study, patients with ADHF had measurable changes in MR–proANP, MR–proADM, and CT–pro–ET–1 24 hours after initial therapy. A study of association with clinical course and outcomes to determine the role of these markers in risk–stratification is warranted.
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor